Background illustration for clinical trials search

Paid Clinical Trials Irving

Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

for
Diabetic Kidney Disease (DKD)
Location: Dallas TX, Arlington TX, DeSoto TX, McKinney TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07271186

Phase2, Recruiting

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

for
Type II Diabetes Mellitus
Location: Dallas TX, Mesquite TX, Stephenville TX,
Sponsor: Corxel Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07340320

Phase2, Recruiting

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

for
Atrophic Vaginitis, Vaginal Atrophy,
Location: Dallas TX, Birmingham AL, West Columbia SC,
Sponsor: Stratpharma AG

Sex: Female

Age: 18+

Code: NCT05953090

Recruiting

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa (HS)
Location: Dallas TX, Bellaire TX, Leawood KS, St Louis MO,
Sponsor: Incyte Corporation

Sex: All

Age: 12 - 17

Code: NCT07213973

Phase2, Recruiting

Pompe Disease Registry Protocol

for
Glycogen Storage Disease Type II, Pompe Disease
Location: Dallas TX, Fort Worth TX, Little Rock AR,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00231400

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

for
Hepatitis B Virus Infection
Location: Webster TX, San Antonio TX, Lenexa KS, Iowa City IA,
Sponsor: GigaGen, Inc.

Sex: All

Age: 18+

Code: NCT07024641

Phase1, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Dallas TX, Frisco TX, Norman OK, Austin TX,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia

for
Schizophrenia
Location: Dallas TX
Sponsor: Matt Byerly

Sex: All

Age: 18 - 60

Code: NCT02282085

Recruiting

Nerve Decompression for Ulcer Recurrence Avoidance (DURA)

for
Diabetic Ulcer of Plantar Aspect of Left Foot,
Location: Denton TX, Houston TX, Jasper IN, Tucson AZ,
Sponsor: Association of Extremity Nerve Surgeons

Sex: All

Age: 18 - 70+

Code: NCT01762085

Recruiting

Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

for
Heart Failure, Inflammation
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 50+

Code: NCT06130059

Phase2, Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: Dallas TX, Denton TX, Oklahoma City OK, Yukon OK,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07039916

Phase3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Dallas TX, Allen TX, Wylie TX, McKinney TX,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase3, Recruiting

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

for
Amyotrophic Lateral Sclerosis (ALS)
Location: Dallas TX, Houston TX, Lincoln NE, Atlanta GA, Tampa FL,
Sponsor: Zydus Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07023835

Phase2, Recruiting

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

for
B-Cell Non-Hodgkin's Lymphoma (NHL), Lymphoma, Non-Hodgkins,
Location: Dallas TX, Salt Lake City UT, Cleveland OH,
Sponsor: Estrella Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT06343311

Phase1, Phase2, Recruiting

Treating Mild Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation

for
Traumatic Brain Injury
Location: Dallas TX
Sponsor: The University of Texas at Dallas

Sex: All

Age: 18 - 70+

Code: NCT04869059

Recruiting

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

for
Breast Cancer, Breast Neoplasms, Breast Cancers
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: All

Age: 18+

Code: NCT06517212

Phase2, Recruiting

Fabry Disease Registry & Pregnancy Sub-registry

for
Fabry Disease
Location: Dallas TX, Fort Worth TX, Little Rock AR,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00196742

Recruiting

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

for
Polymyositis, Dermatomyositis
Location: Colleyville TX, North Richland Hills TX, Allen TX,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06455449

Phase3, Recruiting

Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy

for
Primary Open Angle Glaucoma, Open Angle Glaucoma
Location: Dallas TX
Sponsor: Sanoculis Ltd

Sex: All

Age: 40 - 70+

Code: NCT06313749

Recruiting

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

for
Metastatic Urothelial Carcinoma,
Location: Dallas TX, Atlanta GA, Miami FL, La Jolla CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06439836

Phase1, Recruiting